Efficacy from the ongoing phase I trial Study 1100 with NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with locoregionally recurrent or metastatic HNSCC

Pour en savoir plus sur nos technologies, nos collaborations, nos essais cliniques et d’autres sujets, contactez-nous.